Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Papaverine in Term Premature Rupture of Membranes (PROM)
NCT07826533Recruiting
- Sponsor
- Edith Wolfson Medical Center
- Start
- Mar 2025
- Primary completion
- Apr 2027
- Countries
- 1
01
Overview
Randomised, double-blind trial in premature rupture of membranes (PROM) comparing Papaverine with Placebo (2 arms). Primary endpoint: Time From Study Infusion to Delivery up to 48 hours. Started Mar 2025; status: recruiting.
02
Drugs
papaverine
03
Conditions
premature rupture of membranes (PROM)
Beyond the preview
Go deeper on NCT07826533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07826533.